AAAAAA
Results: 1-25/33
Authors:
Preskill, H
Compton, DW
Baizerman, M
Smith, IE
Citation: H. Preskill et al., Integrating theory and practice - Conceptual frameworks of the CEFP, CANCER PRAC, 9, 2001, pp. S17-S22
Authors:
Daniels, E
King, MA
Smith, IE
Shneerson, JM
Citation: E. Daniels et al., Health-related quality of life in narcolepsy, J SLEEP RES, 10(1), 2001, pp. 75-81
Authors:
Miles, DW
Smith, IE
Coleman, RE
Calvert, AH
Lind, MJ
Citation: Dw. Miles et al., A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer, EUR J CANC, 37(11), 2001, pp. 1366-1371
Authors:
Highcock, MP
Shneerson, JM
Smith, IE
Citation: Mp. Highcock et al., Functional differences in bi-level pressure preset ventilators, EUR RESP J, 17(2), 2001, pp. 268-273
Authors:
Smith, IE
O'Brien, MER
Talbot, DC
Nicolson, MC
Mansi, JL
Hickish, TF
Norton, A
Ashey, S
Citation: Ie. Smith et al., Duration of chemotherapy in advanced non-small-cell lung cancer: A randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin, J CL ONCOL, 19(5), 2001, pp. 1336-1343
Authors:
Sivasothy, P
Brown, L
Smith, IE
Shneerson, JM
Citation: P. Sivasothy et al., Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness, THORAX, 56(6), 2001, pp. 438-444
Authors:
Bromelow, KV
Hirst, W
Mendes, RL
Winkley, AR
Smith, IE
O'Brien, MER
Souberbielle, BE
Citation: Kv. Bromelow et al., Whole blood assay for assessment of the mixed lymphocyte reaction, J IMMUNOL M, 247(1-2), 2001, pp. 1-8
Authors:
Johnston, SRD
Smith, IE
Dowsett, M
Citation: Srd. Johnston et al., Place of aromatase inhibitors in the endocrine therapy of breast cancer, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 29-49
Authors:
Smith, IE
Citation: Ie. Smith, Clinical overview of aromatase inhibitors, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 51-62
Authors:
de Boer, RH
Saini, A
Johnston, SRD
O'Brien, MER
Ellis, PA
Verrill, MW
Prendiville, JA
Walsh, G
Ashley, S
Smith, IE
Citation: Rh. De Boer et al., Continuous infusional combination chemotherapy in inflammatory breast cancer: a phase II study, BREAST, 9(3), 2000, pp. 149-155
Authors:
Stebbing, J
Smith, IE
Citation: J. Stebbing et Ie. Smith, Small cell lung cancer as a cause of acute renal failure secondary to bilateral renal infiltration, CL ONCOL-UK, 12(5), 2000, pp. 326-327
Authors:
De Boer, RH
Allum, WH
Ebbs, SR
Gui, GPH
Johnston, SRD
Sacks, NPM
Walsh, G
Ashley, S
Smith, IE
Citation: Rh. De Boer et al., Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?, ANN ONCOL, 11(9), 2000, pp. 1147-1153
Authors:
Gregory, RK
Johnston, SRD
Smith, IE
Miles, D
Citation: Rk. Gregory et al., UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer, ONCOLOGY-NY, 14(10), 2000, pp. 47-49
Authors:
Sapunar, F
Smith, IE
Citation: F. Sapunar et Ie. Smith, Neoadjuvant chemotherapy for breast cancer, ANN MED, 32(1), 2000, pp. 43-50
Authors:
Smith, IE
Johnston, SRD
O'Brien, MER
Hickish, TF
de Boer, RH
Norton, A
Cirkel, DT
Barton, CM
Citation: Ie. Smith et al., Low-dose oral fluorouracil with eniluracil as first-line chemotherapy against advanced breast cancer: A phase II study, J CL ONCOL, 18(12), 2000, pp. 2378-2384
Authors:
Mendes, R
Bromelow, KV
Westby, M
Galea-Lauri, J
Smith, IE
O'Brien, MER
Souberbielle, BE
Citation: R. Mendes et al., Flow cytometric visualisation of cytokine production by CD3-CD56+NK cells and CD3+CD56+NK-T cells in whole blood, CYTOMETRY, 39(1), 2000, pp. 72-78
Authors:
O'Brien, MER
Saini, A
Smith, IE
Webb, A
Gregory, K
Mendes, R
Ryan, C
Priest, K
Bromelow, KV
Palmer, RD
Tuckwell, N
Kennard, DA
Souberbielle, BE
Citation: Mer. O'Brien et al., A randomized phase II study of SRL172 (Mycobacterium vaccae) combined withchemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma, BR J CANC, 83(7), 2000, pp. 853-857
Authors:
Murray, PV
Soussi, T
O'Brien, MER
Smith, IE
Brossault, S
Norton, A
Ashley, S
Tavassoli, M
Citation: Pv. Murray et al., Serum p53 antibodies: Predictors of survival in small-cell lung cancer?, BR J CANC, 83(11), 2000, pp. 1418-1424
Authors:
Ferguson, JSJ
Summerhayes, M
Masters, S
Schey, S
Smith, IE
Citation: Jsj. Ferguson et al., New treatments for advanced cancer: an approach to prioritization, BR J CANC, 83(10), 2000, pp. 1268-1273
Authors:
Eisen, T
Boshoff, C
Mak, I
Sapunar, F
Vaughan, MM
Pyle, L
Johnston, SRD
Ahern, R
Smith, IE
Gore, ME
Citation: T. Eisen et al., Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer, BR J CANC, 82(4), 2000, pp. 812-817
Authors:
Gregory, RK
Smith, IE
Citation: Rk. Gregory et Ie. Smith, Vinorelbine - a clinical review, BR J CANC, 82(12), 2000, pp. 1907-1913
Authors:
Smith, IE
Citation: Ie. Smith, Aromatase inhibitors: a dose-response effect?, ENDOCR-R CA, 6(2), 1999, pp. 245-249
Authors:
Dowsett, M
Archer, A
Assersohn, L
Gregory, RK
Ellis, PA
Salter, J
Chang, J
Mainwaring, P
Boeddinghaus, I
Johnston, SRD
Powles, TJ
Smith, IE
Citation: M. Dowsett et al., Clinical studies of apoptosis and proliferation in breast cancer, ENDOCR-R CA, 6(1), 1999, pp. 25-28
Authors:
Dowsett, M
Pfister, C
Johnston, SRD
Miles, DW
Houston, SJ
Verbeek, JA
Gundacker, H
Sioufi, A
Smith, IE
Citation: M. Dowsett et al., Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer, CLIN CANC R, 5(9), 1999, pp. 2338-2343
Authors:
Johnston, SRD
Lu, B
Scott, GK
Kushner, PJ
Smith, IE
Dowsett, M
Benz, CC
Citation: Srd. Johnston et al., Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance, CLIN CANC R, 5(2), 1999, pp. 251-256